M2RLAB
About
We are a clinical-stage biopharmaceutical company with a proprietary cellular therapy tech platform that is applicable in a myriad of diseases with an acute, inflammatory and fibrotic common environment. We have gone from designing our therapy platform to beginning our clinical program with an approved Phase I/II clinical trial for Acute Kidney Injury, a disease with no effective treatment alternative with our cell therapy. We also develope work in other two inflammatory and fibrotic unresolved deseases.
Business Domain / 分野
Business Type / 業種
Modalities / モダリティ
Disease Area / 疾患領域
Additional Information
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術